Novavax Jumps After Starting Covid-19 Vaccine Study

(Bloomberg) -- Novavax Inc. jumped at much as 18% on Tuesday after initiating testing of its coronavirus vaccine candidate in people. The biotech anticipates providing a first look in July at what ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.